Inventor · disambiguated record

Christophe Tratrat

Also filed as: TRATRAT CHRISTOPHE

103 granted patents·41 citations·filing 2000–2024

98Inventor score

Technology areasC07D A61P A61K

Files withUNIV KING FAISAL102 SERVIER LAB1

Top patents by PatentIndex Score

103 records

0196US11897883B1Pyrrolo[3,2-c][1,6]naphthyridine-2-carboxylic acid compounds as CK2 inhibitorsUNIV KING FAISAL·Filed 2023·Granted Feb 13, 2024·3 cites·19 claims
0296US11802130B1Benzofuro[3,2-c]chromen-6-one compounds as antibacterial agentsUNIV KING FAISAL·Filed 2023·Granted Oct 31, 2023·2 cites·16 claims
0395US11964974B1Imidazo[1,2-c]pyrido[3,4-e]pyrimidine-3-carboxylic acids as CK2 inhibitorsUNIV KING FAISAL·Filed 2024·Granted Apr 23, 2024·2 cites·20 claims
0495US11905289B1Pyrido[3′,4′:4,5]pyrrolo[3,2-C]naphthyridine compounds as CK2 inhibitorsUNIV KING FAISAL·Filed 2023·Granted Feb 20, 2024·2 cites·15 claims
0594US11964975B15-substituted aminopyrimido[6′,1′:2,3]imidazo[4,5-c][2,6]naphthyridine compounds as CK2 inhibitorsUNIV KING FAISAL·Filed 2023·Granted Apr 23, 2024·1 cites·13 claims
0694US11945820B1Pyrrolo[3,2-c][2,6]naphthyridine-2-carboxylic acid compounds as CK2 inhibitorsUNIV KING FAISAL·Filed 2023·Granted Apr 2, 2024·1 cites·15 claims
0794US11884667B1Substituted pyrrolo[2,3-c][2,7]naphthyridines as CK2 inhibitorsUNIV KING FAISAL·Filed 2023·Granted Jan 30, 2024·2 cites·11 claims
0893US11999736B1Pyrazino[2′,1′:2,3]imidazo[4,5-b][1,7]naphthyridines compounds as CK2 inhibitorsUNIV KING FAISAL·Filed 2023·Granted Jun 4, 2024·2 cites·20 claims
0993US11976079B1Pyrazino[1′,2′:1,5]pyrazolo[4,3-b][1,6]naphthyridines compounds as CK2 inhibitorsUNIV KING FAISAL·Filed 2023·Granted May 7, 2024·1 cites·13 claims
1092US12134617B1Pyrimido[1′6′:1,5]pyrazolo[4,3-c][1,7]naphthyridines as CK2 inhibitorsUNIV KING FAISAL·Filed 2024·Granted Nov 5, 2024·1 cites·16 claims
1192US11987581B1Imidazo[1,2-c]pyrido[3,4-e]pyrimidine-2-carboxylic acids as CK2 inhibitorsUNIV KING FAISAL·Filed 2023·Granted May 21, 2024·1 cites·20 claims
1292US11981676B1Pyrazolo[4,3-c][2,6]naphthyridines as CK2 inhibitorsUNIV KING FAISAL·Filed 2024·Granted May 14, 2024·1 cites·20 claims
1392US11952378B1Pyrrolo[2,3-c]isoquinoline-1,2-dione compounds as CK2 inhibitorsUNIV KING FAISAL·Filed 2023·Granted Apr 9, 2024·1 cites·18 claims
1492US11807640B17-isopropyl 1-ethyl/methyl 3-(substituted benzoyl)-2-substituted indolizine-1,7-dicarboxylates as anti-tubercular agentsUNIV KING FAISAL·Filed 2023·Granted Nov 7, 2023·2 cites·16 claims
1592US11807607B1Aminocarbazole compounds as antibacterial agentsUNIV KING FAISAL·Filed 2023·Granted Nov 7, 2023·1 cites·19 claims
1691US11926629B1Pyrido[3′,4′:4,5]pyrrolo[2,3-c]isoquinoline compounds as CK2 inhibitorsUNIV KING FAISAL·Filed 2023·Granted Mar 12, 2024·1 cites·15 claims
1791US11891377B1Pyrrolo[3,2-c][2,7]naphthyridine-2-carboxylic acid compounds as CK2 inhibitorsUNIV KING FAISAL·Filed 2023·Granted Feb 6, 2024·1 cites·16 claims
1891US11891394B1Pyrrolo[2,3-c][1,6]naphthyridine-8-carboxylic acid compounds as CK2 inhibitorsUNIV KING FAISAL·Filed 2023·Granted Feb 6, 2024·1 cites·19 claims
1991US11891397B1Pyrido[4′,3′:4,5]pyrrolo[3,2-c][1,7]naphthyridin-10-one compounds as CK2 inhibitorsUNIV KING FAISAL·Filed 2023·Granted Feb 6, 2024·1 cites·20 claims
2091US11884670B1Pyrido[4′,3′:4,5]pyrrolo[3,2-c][2,7]naphthyridin-10-one compounds as CK2 inhibitorsUNIV KING FAISAL·Filed 2023·Granted Jan 30, 2024·1 cites·15 claims
2191US11884669B1Pyrrolo[3,2-c][1,7]naphthyridine-2-carboxylic acid compounds as CK2 inhibitorsUNIV KING FAISAL·Filed 2023·Granted Jan 30, 2024·1 cites·18 claims
2291US11884668B1Substituted pyrido[3′,4′:4,5]pyrrolo[2,3-c]quinolines as CK2 inhibitorsUNIV KING FAISAL·Filed 2023·Granted Jan 30, 2024·1 cites·11 claims
2391US11866437B11,2-dioxo-2,3-dihydro-1H-pyrrolo[2,3-c]quinoline-7-carboxylic acid compounds as CK2 inhibitorsUNIV KING FAISAL·Filed 2023·Granted Jan 9, 2024·1 cites·20 claims
2491US11858935B1Pyrrolo[2,3-c][1,7]naphthyridine-2-carboxylic acid compounds as CK2 inhibitorsUNIV KING FAISAL·Filed 2023·Granted Jan 2, 2024·1 cites·20 claims
2591US11731980B1Furo[3,4-b]quinolone compounds as antibacterial agentsUNIV KING FAISAL·Filed 2023·Granted Aug 22, 2023·1 cites·17 claims
2690US11964976B1Substituted pyrido[3′,4′:4,5]pyrrolo[3,2-c][1,6]naphthyridines as CK2 inhibitorsUNIV KING FAISAL·Filed 2023·Granted Apr 23, 2024·1 cites·11 claims
2785US12180218B1Substituted pyrimido[4,5-b]indoles as CK2 inhibitorsUNIV KING FAISAL·Filed 2024·Granted Dec 31, 2024·0 cites·4 claims
2885US12129260B2Benzofuro[3,2-c]chromen-6-one compounds as antibacterial agentsUNIV KING FAISAL·Filed 2023·Granted Oct 29, 2024·0 cites·13 claims
2984US11976080B1Benzofuro[3,2-c]chromen-6-one compounds as antibacterial agentsUNIV KING FAISAL·Filed 2023·Granted May 7, 2024·0 cites·6 claims
3084US11964981B1Substituted pyrimido[4,5-b]indoles as CK2 inhibitorsUNIV KING FAISAL·Filed 2023·Granted Apr 23, 2024·0 cites·7 claims
3184US11945821B15-substituted aminopyrazino[2′,1′:2,3]imidazo[4,5-C][2,7]naphthyridine compounds as CK2 inhibitorsUNIV KING FAISAL·Filed 2023·Granted Apr 2, 2024·0 cites·10 claims
3283US12006317B15-substituted aminopyrimido [6′,1′:2,3] imidazo [4,5-c] [2,6] naphthyridine compounds as CK2 inhibitorsUNIV KING FAISAL·Filed 2023·Granted Jun 11, 2024·0 cites·11 claims
3383US11999735B15-substituted aminopyrimido [6′,1′:2,3] imidazo [4,5-c] [2,6] naphthyridine compounds as CK2 inhibitorsUNIV KING FAISAL·Filed 2023·Granted Jun 4, 2024·0 cites·10 claims
3483US11952383B1Aza-podophyllotoxin analogues as potential anti-cancer agentsUNIV KING FAISAL·Filed 2023·Granted Apr 9, 2024·0 cites·12 claims
3583US11891395B15-substituted aminopyrazino[2′,1′:2,3]imidazo[4,5-C][2,7]naphthyridine compounds as CK2 inhibitorsUNIV KING FAISAL·Filed 2023·Granted Feb 6, 2024·0 cites·15 claims
3682US11970496B1Pyrrolo[3,2-c]quinoline compounds as CK2 inhibitorsUNIV KING FAISAL·Filed 2023·Granted Apr 30, 2024·0 cites·11 claims
3782US11958851B1Pyrrolo[3,2-c]quinoline compounds as CK2 inhibitorsUNIV KING FAISAL·Filed 2023·Granted Apr 16, 2024·0 cites·10 claims
3881US12286436B2Substituted pyrimido[4,5-b]indoles as CK2 inhibitorsUNIV KING FAISAL·Filed 2024·Granted Apr 29, 2025·0 cites·10 claims
3981US11945818B1Pyrrolo[3,2-c]quinoline compounds as CK2 inhibitorsUNIV KING FAISAL·Filed 2023·Granted Apr 2, 2024·0 cites·14 claims
4081US11858893B1Aza-Podophyllotoxin analogues as potential anti-cancer agentsUNIV KING FAISAL·Filed 2023·Granted Jan 2, 2024·0 cites·3 claims
4180US12180209B1Pyrrolo[3,2-c][2,6]naphthyridine-2-carboxylic acid compounds as CK2 inhibitorsUNIV KING FAISAL·Filed 2024·Granted Dec 31, 2024·0 cites·3 claims
4280US12173003B1Pyrrolo[3,2-C][2,6]naphthyridine-2-carboxylic acid compounds as CK2 inhibitorsUNIV KING FAISAL·Filed 2024·Granted Dec 24, 2024·0 cites·1 claims
4380US12018028B15-substituted aminopyrazino[2′,1′:2,3]imidazo[4,5-c][2,7]naphthyridine compounds as CK2 inhibitorsUNIV KING FAISAL·Filed 2023·Granted Jun 25, 2024·0 cites·11 claims
4480US11905290B15-substituted aminopyrimido[6′,1′:2,3]imidazo[4,5-c][1,6]naphthyridine compounds as CK2 inhibitorsUNIV KING FAISAL·Filed 2023·Granted Feb 20, 2024·0 cites·12 claims
4580US11820779B1Aza-podophyllotoxin analogues as potential anti-cancer agentsUNIV KING FAISAL·Filed 2023·Granted Nov 21, 2023·0 cites·11 claims
4679US11976070B1Substituted pyrimido[6â€™, 1â€™:2,3]imidazo[4,5-c][1,6]naphthyridines as CK2 inhibitorsUNIV KING FAISAL·Filed 2023·Granted May 7, 2024·0 cites·22 claims
4779US11845743B1Pyrazolidinedione derivatives and their use as PPAR-gamma inhibitorsUNIV KING FAISAL·Filed 2023·Granted Dec 19, 2023·0 cites·8 claims
4878US12129259B1Pyrazino[1′,2′:1,5]pyrazolo[4,3-b][1,6]naphthyridines compounds as CK2 inhibitorsUNIV KING FAISAL·Filed 2024·Granted Oct 29, 2024·0 cites·18 claims
4977US11958847B1Pyrazolidinedione derivatives and their use as PPAR-gamma inhibitorsUNIV KING FAISAL·Filed 2023·Granted Apr 16, 2024·0 cites·4 claims
5077US11932640B1Pyrrolo[3,4-b]quinoline compounds as antibacterial agentsUNIV KING FAISAL·Filed 2023·Granted Mar 19, 2024·0 cites·9 claims

Showing the top 50 of 103 patent records by PatentIndex Score.

Join the waitlist — get patent alerts

Get an alert when Christophe Tratrat files or is granted a new patent.

We store only your email — no account needed. See our privacy policy.

Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →